000			01686nam a2200325Ia 4500
001			309857
003			OCoLC
005			20160527190154.0
008			120730s2011 oncod b 001 0 eng d
020			_a9780973075069
020			_a0973075066
035			_a(OCoLC)802251579
040			_aPUCPR
049			_acicg
050		4	_aKE 2919 _b.L54 2011
245	0	0	_aLife sciences & chemical patent practice in Canada _ba practical guide.
246	3		_aLife sciences and chemical patent practice in Canada
250			_a3rd. ed.
260			_a[Toronto, ON?] _bBorden Ladner Gervais LLP _cc2011.
300			_axviii, 184 p. _bill. _c24 cm.
504			_aIncludes bibliographical references and index.
500			_aIncludes table of cases.
500			_aPrevious editions titled: Biotechnology and chemical patent practice in Canada.
505	0		_aOverview of the Canadian patent system -- Procedural requirements -- Biotechnology-specific procedural requirements -- Chemical compounds -- Biopolymers : DNA, RNA, and proteins -- Antibodies -- Living matter (life forms) -- Medical treatments and medical uses -- Bioinformatics, diagnostic technologies, and biomarkers -- Plant breeders' rights -- Patented medicines (notice of compliance) regulations -- Patented medicine prices review board -- Subsequent entry biologics -- Infringement, validity, and post-grant modifications.
650		0	_aPatent practice _zCanada. _9148197 _2Local
650		0	_aChemicals _zCanada _vPatents. _972291 _2Local
650		0	_aBiotechnology _zCanada _vPatents. _962503 _2Local
710	2		_aBorden Ladner Gervais LLP. _9203472 _2Local
730	0		_aBiotechnology and chemical patent practice in Canada.
999			_c227956 _d227956